Similar articles

• Authors' reply to: "Empiric" inositol supplementation in normal-weight non-insulin resistant women with polycystic ovarian disease: from the absence of benefit to the potential adverse effects.

  Laganà AS, Pizzo A. Laganà AS, et al. Arch Gynecol Obstet. 2015 May;291(5):959-60. doi: 10.1007/s00404-015-3663-8. Arch Gynecol Obstet. 2015. PMID: 25687660 No abstract available.
• Evaluation of ovarian function and metabolic factors in women affected by polycystic ovary syndrome after treatment with D-Chiro-Inositol.

  Laganà AS, Barbaro L, Pizzo A. Laganà AS, et al. Arch Gynecol Obstet. 2015 May;291(5):1181-6. doi: 10.1007/s00404-014-3552-6. Epub 2014 Nov 22. Arch Gynecol Obstet. 2015. PMID: 25416201
• [Effects of inositol on oocyte quality in patients affected with polycystic ovary syndrome].

  Ciotta L, Stracquadanio M, Pagano I, Carbonaro A, Palumbo M, Gulino F. Ciotta L, et al. Minerva Ginecol. 2010 Dec;62(6):525-31. Minerva Ginecol. 2010. PMID: 21079574 Italian.
• [The role of inositol deficiency in the etiology of polycystic ovary syndrome disorders].

  Jakimiuk AJ, Szamatowicz J. Jakimiuk AJ, et al. Ginekol Pol. 2014 Jan;85(1):54-7. doi: 10.17772/gp/1691. Ginekol Pol. 2014. PMID: 24505965 Review. Polish.
• Inositols in Polycystic Ovary Syndrome: An Overview on the Advances.

  Facchinetti F, Unfer V, Dewailly D, Kamenov ZA, Diamanti-Kandarakis E, Laganà AS, Nestler JE, Soulage CO; Group of 'Inositol in PCOS and Reproduction'. Facchinetti F, et al. Trends Endocrinol Metab. 2020 Jun;31(6):435-447. doi: 10.1016/j.tem.2020.02.002. Epub 2020 Mar 9. Trends Endocrinol Metab. 2020. PMID: 32396844 Review.